Ludwig Edward J's Form 4 filing
Boston Scientific Corp (BSX) · filed Feb 12, 2025
- Accession no.
- 0001225208-25-001594
- Filed
- Feb 12, 2025
- Trade date
- Feb 11, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $1.27M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ludwig Edward JCIK 0001221783 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2025 | Common Stock | GGiftDisposed | −3,000 | $0.00 | $0 | 36,398 | Direct | |
| Feb 11, 2025 | Common Stock | SSaleDisposed | −12,000 | $105.48F1 | −$1,265,760 | 24,398 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $105.47 to $105.55, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.